Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer
2018 · Cell · 590 citations
https://doi.org/10.1016/j.cell.2018.04.034
E
Elisabeth I. Heath
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
1.2K
Papers
20.0K
Citations
60
h-index
213
i10-index
Elisabeth I. Heath is an academic researcher. The author has contributed to research in topics: Prostate Cancer Treatment and Research & Cancer Immunotherapy and Biomarkers & Hormonal and reproductive studies. The author has an h-index of 60, co-authored 1020 publications.
ORCID: 0000-0003-1381-2713Papers by this author
worksIntegrative Clinical Genomics of Advanced Prostate Cancer
2015 · Cell · 570 citations
https://doi.org/10.1016/j.cell.2015.06.053
Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry
2020 · Prostate Cancer and Prostatic Diseases · 142 citations
https://doi.org/10.1038/s41391-020-0213-7
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study
2024 · Journal of Clinical Oncology · 137 citations
https://doi.org/10.1200/jco.23.01569
A Phase Ib/IIa Study of the Pan-BET Inhibitor ZEN-3694 in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer
2020 · Clinical Cancer Research · 126 citations
https://doi.org/10.1158/1078-0432.ccr-20-1707
Pharmacological targeting of CXCL12/CXCR4 signaling in prostate cancer bone metastasis
2016 · Molecular Cancer · 115 citations
https://doi.org/10.1186/s12943-016-0552-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat